Preliminary experiments point out conolidine might inhibit precise ion channels, minimizing neuronal excitability and restricting soreness indicators. This mechanism is particularly suitable in neuropathic ache, wherever abnormal signaling will cause persistent discomfort. Also, conolidine seems to impact G protein-coupled receptor (GPCR) pathways